Study Compares Baricitinib to Dexamethasone for COVID-19
Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.